A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2025-052 B 股证券代码：900906 B 股证券简称：中毅达 B 一、董事会会议召开情况 贵州中毅达股份有限公司（以下简称"公司"）第九届董事会第十三次会议 （以下简称"本次会议"）于 2025 年 10 月 27 日以现场与通讯表决相结合的方 式在公司会议室召开。会议应出席董事 7 名，实际出席董事 7 名。公司已于 2025 年 10 月 24 日以邮件、微信等方式将会议通知、会议文件发送至各位董事。本次 会议的召开符合《公司法》《公司章程》的有关规定。会议由董事长申苗女士召 集并主持，公司监事和高级管理人员列席了本次会议。 二、董事会会议审议情况 （一）审议通过《关于<2025 年第三季度报告>的议案》 详见公司同日披露的《2025 年第三季度报告》。 表决结果：同意票 7 票；反对票 0 票；弃权票 0 票。 本议案在提交董事会前已经公司第九届董事会审计委员会第十四次会议审 议通过，并同意提交董事会审议。 贵州中毅达股份有限公司 第九届董事会第十三次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 ...

Core Viewpoint - Zhongyida (600610) reported a significant increase in net profit for Q3 2025, driven by higher prices of its products and adjustments in production plans [1] Financial Performance - Q3 revenue reached 260 million yuan, representing a year-on-year growth of 5.84% [1] - Net profit for Q3 was 5.571 million yuan, showing a remarkable year-on-year increase of 759.72% [1] - For the first three quarters, net profit amounted to 45.1059 million yuan, indicating a turnaround from losses in the previous year [1] Product and Market Impact - The increase in net profit was primarily attributed to a significant rise in the prices of the company's pentanediol series products, which boosted the gross margin [1] - The company made reasonable adjustments to the production plans for alcohol and other products that were operating at a loss, which contributed to reducing losses [1]

Core Insights - The company Zhongyida (600610.SH) reported a significant increase in net profit for Q3 2025, with a year-on-year growth of 759.72% [2] - The revenue for Q3 2025 reached 260 million yuan, marking a 5.84% increase compared to the same period last year [2] - For the first three quarters of 2025, the company experienced a decline in revenue by 6.07%, totaling 762 million yuan, while net profit stood at 45.11 million yuan [2] Financial Performance - Q3 2025 revenue: 260 million yuan, up 5.84% year-on-year [2] - Q3 2025 net profit: 5.57 million yuan, up 759.72% year-on-year [2] - First three quarters 2025 revenue: 762 million yuan, down 6.07% year-on-year [2] - First three quarters 2025 net profit: 45.11 million yuan [2] Operational Factors - The substantial growth in net profit is attributed to the price increase of the company's pentanediol series products, which led to an improvement in gross margin [2] - The company optimized production plans for alcohol and other facilities that were previously operating at a loss, contributing to reduced losses [2]

Financial Performance - The company's operating revenue for the third quarter was ¥259,865,799.25, an increase of 5.84% compared to the same period last year[4] - The total profit for the third quarter reached ¥12,154,102.78, representing a significant increase of 186.87% year-on-year[4] - The net profit attributable to shareholders was ¥5,570,997.00, showing a remarkable growth of 759.72% compared to the previous year[4] - The basic earnings per share for the third quarter was ¥0.0052, reflecting a 766.67% increase compared to the same period last year[5] - Total operating revenue for the first three quarters of 2025 was CNY 761.65 million, a decrease of 6.06% compared to CNY 810.87 million in the same period of 2024[21] - Net profit for the first three quarters of 2025 was CNY 45.11 million, a significant recovery from a net loss of CNY 15.08 million in the same period of 2024[22] - The company reported a total comprehensive income of CNY 45.11 million for the first three quarters of 2025, compared to a loss of CNY 15.08 million in the same period of 2024[23] - Earnings per share for the first three quarters of 2025 were CNY 0.0421, compared to a loss per share of CNY -0.0141 in the same period of 2024[23] Cash Flow and Assets - The cash flow from operating activities for the year-to-date period was ¥120,938,196.64, a decrease of 13.49% year-on-year[4] - Operating cash flow for the first three quarters of 2025 was CNY 120.94 million, compared to CNY 139.80 million in the same period of 2024, reflecting a decrease of 13.5%[26] - Cash and cash equivalents increased to CNY 168,022,431.18 from CNY 95,521,251.59, representing a significant growth of approximately 76.00%[17] - Cash and cash equivalents increased by $72,600,100.26, compared to an increase of $44,084,373.09 in the prior period[27] - The ending balance of cash and cash equivalents reached $159,255,608.22, up from $88,064,743.62 at the beginning of the period[27] Equity and Liabilities - The weighted average return on equity increased by 3.76 percentage points to 5.05% for the third quarter[5] - Total assets at the end of the reporting period were ¥1,039,540,385.29, an increase of 2.38% from the end of the previous year[5] - The equity attributable to shareholders increased by 71.20% to ¥113,504,875.28 compared to the previous year[5] - The company's current assets totaled CNY 430,232,701.00, up from CNY 355,272,131.40 in the previous year, indicating an increase of about 21.11%[18] - The total liabilities decreased to CNY 926,035,510.01 from CNY 949,074,293.24, indicating a reduction of approximately 2.43%[19] - The company's non-current liabilities increased to CNY 788,088,092.60 from CNY 761,915,367.26, reflecting an increase of about 3.43%[19] - The total equity remained stable at CNY 1,071,274,605.00, unchanged from the previous year[19] Strategic Initiatives - The company adjusted its production plans for low-margin products, contributing to the significant increase in net profit[8] - The company has completed the disposal of three subsidiaries without generating actual profits, as part of its asset disposal strategy[13] - Guizhou Zhongyida has initiated bankruptcy proceedings for one of its subsidiaries, indicating ongoing restructuring efforts[14] - The company plans to expedite the asset disposal process in accordance with its commitments[15] - The company plans to focus on market expansion and new product development to drive future growth[21] Research and Development - Research and development expenses for the first three quarters of 2025 were CNY 9.13 million, down 25.5% from CNY 12.22 million in the same period of 2024[21] - Financial expenses decreased to CNY 23.31 million, down 23.7% from CNY 30.55 million year-over-year[21]

Core Viewpoint - The company reported a revenue of 260 million yuan for Q3 2025, reflecting a year-on-year growth of 5.84%, while the net profit reached 5.571 million yuan, showing a significant increase of 759.72% [1] Financial Performance - For the first three quarters of 2025, the company's revenue totaled 762 million yuan, which represents a year-on-year decline of 6.07% [1] - The net profit for the same period was 45.1059 million yuan [1]

Core Viewpoint - The report from Guosen Securities indicates that the implementation of the 2026 refrigerant quota reduction for second-generation refrigerants and the continuation of the third-generation refrigerant quota system will maintain a tight supply-demand balance for mainstream refrigerants like R32 and R134a, with significant long-term price upside potential [1][2]. Regulatory Framework - The Ministry of Ecology and Environment has issued the quota setting and distribution plan for 2026, emphasizing strict compliance with the annual phase-out tasks for second-generation refrigerants and making slight adjustments to the third-generation refrigerant quotas, increasing the inter-species adjustment limit from 10% to 30% [1][3]. Production Quotas - For HCFCs, the production quota for 2026 is set at 151,400 tons, with a reduction of 71.5% and 76.1% from baseline values for production and usage, respectively. The R22 production quota will see a year-on-year reduction of 3,000 tons, which is a decrease of 2.01% [3][4]. Market Dynamics - R22 prices have stabilized after a decline, while R32 and R134a continue to show strong market conditions. The average price of R22 fell to 34,100 CNY/ton in Q3 2025, while R32's average price rose to 59,000 CNY/ton, reflecting a strong demand [5]. Investment Opportunities - Companies with complete industrial chains, robust infrastructure, leading refrigerant quotas, and advanced technology in fluorochemical production are recommended for investment. Notable companies include Juhua Co., Ltd. (600610.SH), Dongyue Group (00189), and Sanmei Co., Ltd. (603379.SH) [6].

Market Overview - On October 23, the chemical raw materials sector rose by 1.17%, with Shilong Industrial leading the gains [1] - The Shanghai Composite Index closed at 3922.41, up 0.22%, while the Shenzhen Component Index closed at 13025.45, also up 0.22% [1] Top Performers - Shilong Industrial (002748) closed at 13.98, up 9.99% with a trading volume of 286,600 shares and a transaction value of 394 million [1] - Kaisheng New Materials (301069) closed at 25.02, up 6.97% with a trading volume of 348,800 shares [1] - Zhongyida (600610) closed at 12.15, up 4.83% with a trading volume of 879,500 shares [1] Underperformers - Sanqi Co. (603938) saw a decline of 10.00%, closing at 17.73 with a trading volume of 326,900 shares and a transaction value of 589 million [2] - Chiyanjingshen (663299) decreased by 6.17%, closing at 11.56 with a trading volume of 378,800 shares [2] - Hengguang Co. (301118) fell by 3.88%, closing at 25.00 with a trading volume of 54,400 shares [2] Capital Flow - The chemical raw materials sector experienced a net outflow of 48.83 million from institutional investors, while retail investors saw a net inflow of 205 million [2] - The overall capital flow indicates a mixed sentiment, with institutional investors pulling back while retail investors are more active [2] Individual Stock Capital Flow - Zhongyida (600610) had a net inflow of 103 million from institutional investors, while retail investors showed a net outflow of approximately 97 million [3] - Shilong Industrial (002748) recorded a net inflow of 31.81 million from institutional investors, with retail investors also showing a net outflow [3] - Kaisheng New Materials (301069) had a net inflow of 52.49 million from institutional investors, while retail investors experienced a net outflow of about 49.64 million [3]

Group 1 - The core viewpoint of the news is that Zhongyida's stock has shown significant volatility, with a year-to-date increase of 173.76% despite recent declines in the short term [1][2] - As of October 22, Zhongyida's stock price was 11.58 CNY per share, with a market capitalization of 12.405 billion CNY and a trading volume of 46.4892 million CNY [1] - The company has seen a net inflow of main funds amounting to 337,400 CNY, with significant buying and selling activity from large orders [1] Group 2 - Zhongyida's main business involves the production and sales of fine chemical products, with the revenue composition being 61.86% from pentaerythritol series products, 11.91% from edible alcohol, 10.95% from trimethylolpropane series products, and 7.46% from DDGS feed [1] - The company belongs to the basic chemical industry, specifically in the category of chemical raw materials [2] - As of September 19, the number of shareholders decreased by 10.23% to 126,900, while the average circulating shares per person remained unchanged [2]

Core Viewpoint - The company held a half-year performance briefing on October 17, 2025, to provide insights into its operational results and financial status for the first half of 2025, following the release of its semi-annual report on August 26, 2025 [1] Group 1: Performance Overview - The company's revenue decreased while net profit increased due to rising prices of its core product, the pentose series, which improved gross margins [2] - The company strategically reduced the production of alcohol devices with negative gross margins, contributing to the decline in revenue [2] - The company aims to enhance product competitiveness and improve operational performance while adjusting according to market conditions [4] Group 2: Market and Stock Performance - The company acknowledged that stock price fluctuations are influenced by various factors, including macroeconomic conditions, industry cycles, and market sentiment [3] - The company emphasized its compliance with information disclosure regulations and reassured investors that there are no undisclosed material facts [3] Group 3: Future Outlook - The company indicated that its production and operations are currently normal and will continue to focus on its core business [4] - The company will provide updates on its performance trends in future periodic reports and announcements [4] Group 4: Market Position - The company's pentose series products accounted for approximately 25% of the actual production capacity of pentose in the country for the year 2024, according to industry research [6]

关于 2025 年半年度业绩说明会召开情况的公告 贵州中毅达股份有限公司 A 股证券代码：600610 A 股证券简称：中毅达 公告编号：2025-051 B 股证券代码：900906 B 股证券简称：中毅达 B 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、业绩说明会召开情况 2025 年 10 月 17 日下午 14:00-15:00，公司通过上海证券交易所上证路演中 心（http://roadshow.sseinfo.com/）以文字互动方式召开了 2025 年半年度业绩说明 会。公司董事长申苗女士、总经理全宏冬先生、董事、财务总监蔡文洁女士、独 立董事季喜花女士、副总经理兼董事会秘书朱新刚先生出席了本次会议，通过网 络文字互动方式与投资者进行了沟通交流。 二、投资者提出的主要问题及公司回复情况 问题 1：公司营收下降净利润提高的原因是什么？ 回复：2025 年上半年，受市场情况影响，公司核心产品季戊四醇系列产品 价格逐步上升推动毛利率上升，使得公司净利润同比增长。此外，公司根据市场 情况有计划地降低毛利率为 ...